These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 7173315
1. Regulation of [3H]imipramine binding sites in rat brain regions: effect of neonatal 5,7-dihydroxytryptamine treatment. Hrdina PD, Pappas BA, Bialik RJ, Ryan CL. Eur J Pharmacol; 1982 Sep 24; 83(3-4):343-4. PubMed ID: 7173315 [No Abstract] [Full Text] [Related]
3. Intrahypothalamic 5,7-dihydroxytryptamine facilitates feminine sexual behavior and decreases [3H]imipramine binding and 5-HT uptake. Luine VN, Frankfurt M, Rainbow TC, Biegon A, Azmitia E. Brain Res; 1983 Apr 04; 264(2):344-8. PubMed ID: 6850308 [Abstract] [Full Text] [Related]
4. 3H-Imipramine binding sites in the rat brain. Selective localization on serotoninergic neurones. Gross G, Göthert M, Ender HP, Schümann HJ. Naunyn Schmiedebergs Arch Pharmacol; 1981 Apr 04; 317(4):310-4. PubMed ID: 7322215 [No Abstract] [Full Text] [Related]
5. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals. Towle AC, Breese GR, Mueller RA, Coyle S, Lauder JM. Brain Res; 1984 Sep 17; 310(1):67-75. PubMed ID: 6383521 [Abstract] [Full Text] [Related]
6. Distribution of the radioactivity in the central nervous system of the developing rat following intracisternal or subcutaneous administration of 14C-5,7-dihydroxytryptamine. Sievers J, Baumgarten HG, Klemm HP, Schlossberger HG, Lolova I. Bibl Anat; 1981 Sep 17; (19):302-7. PubMed ID: 7225075 [No Abstract] [Full Text] [Related]
7. Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity. Lucot JB, Seiden LS. Psychopharmacology (Berl); 1982 Sep 17; 77(2):114-6. PubMed ID: 6812128 [Abstract] [Full Text] [Related]
8. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone. McIntyre IM, Oxenkrug GF, Stanley M, Gershon S. Brain Res; 1984 Aug 20; 309(1):156-8. PubMed ID: 6488005 [Abstract] [Full Text] [Related]
9. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat. Nelson DL, Herbet A, Bourgoin S, Glowinski J, Hamon M. Mol Pharmacol; 1978 Nov 20; 14(6):983-95. PubMed ID: 732817 [No Abstract] [Full Text] [Related]
10. Sodium-dependent [3H]imipramine binding in rat hippocampus and its relationship to serotonin uptake. Hrdina PD. Can J Physiol Pharmacol; 1987 Dec 20; 65(12):2422-7. PubMed ID: 2452679 [Abstract] [Full Text] [Related]
11. Evaluation of body weight changes after selective serotonin depletion with 5,7-dihydroxytryptamine. Baez LA, Browning RA, Cusatis M. Prog Neuropsychopharmacol; 1980 Dec 20; 4(2):123-7. PubMed ID: 7403347 [No Abstract] [Full Text] [Related]
15. Relationship between levels and uptake of serotonin and high affinity [3H]imipramine recognition sites in the rat brain. Hrdina PD, Pappas BA, Roberts DC, Bialik RJ, Ryan CL. Can J Physiol Pharmacol; 1985 Oct 20; 63(10):1239-44. PubMed ID: 3000552 [Abstract] [Full Text] [Related]
16. Effect of substance P on the 5,7-dihydroxytryptamine induced alteration of the postnatal development of central serotonin neurons. Jonsson G, Hallman H. Med Biol; 1983 Apr 20; 61(2):105-12. PubMed ID: 6192293 [Abstract] [Full Text] [Related]
17. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment. Kirby ML, Mattio TG. Dev Neurosci; 1982 Apr 20; 5(5-6):394-402. PubMed ID: 6186451 [Abstract] [Full Text] [Related]